According the report, Alpha Radioimmunotherapy-Based Targeted Cancer Treatment is one of the primary growth factors for the market. Increasing Incidence and Prevalence of Target Conditions is also expected to contribute significantly to the Nuclear Medicine market. Overall, Oncology applications of Nuclear Medicine, and the growing awareness of them, is what makes this segment of the industry important to its overall growth.

AMA’s Analyst on the Global Nuclear Medicine market identified that the demand is rising in many different parts of the world as "Use of Radiopharmaceuticals in Neurological Applications". One of the challenges that industry facing is "Hospital Budget Cuts and High Equipment Prices"

The Procedural Volume Assessment, such as Diagnostic Procedures, is boosting the Nuclear Medicine market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.

The End Use, such as Hospitals, is boosting the Nuclear Medicine market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.

The report provides an in-depth analysis and forecast about the industry covering the following key features:
o Industry outlook including current and future market trends, drivers, restraints, and emerging technologies
o Analyses the Global Nuclear Medicine market according to Type, Application, and regions
o Analyzes the top 10 players in terms of market reach, business strategy, and business focus
o Provides stakeholders’ insights and key drivers & trends of the market

Market Size Estimation
In market engineering method, both top-down and bottom-up approaches have been used, along with various data triangulation process, to predict and validate the market size of the Nuclear Medicine market and other related sub-markets covered in the study.

o Key & emerging players in the Nuclear Medicine market have been observed through secondary research.
o The industry’s supply chain and overall market size, in terms of value, have been derived through primary and secondary research processes.
o All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation
The overall Nuclear Medicine market size is calculated using market estimation process, the Nuclear Medicine market was further split into various segments and sub-segments. To complete the overall market engineering and arriving at the exact statistics for all segments and sub-segments, the market breakdown and data triangulation procedures have been utilized, wherever applicable. The data have been triangulated by studying various influencing factors and trends identified from both demand and supply sides of various applications involved in the study. Along with this, the Global Nuclear Medicine market size has been validated using both top-down and bottom-up approaches.